Bharat Biotech on Saturday received approval for emergency use authorisation of the Covaxin Covid-19 vaccine for children in the 12-18 years age group by the Drug Controller General of India (DGCI), said authorities.
Covaxin is now the second vaccine cleared for use for children in India. In August, The Drugs Controller General of India (DCGI) gave approval for emergency-use authorization of Zydus Cadila’s ZyCoV-D vaccine, the Union Ministry of Science and Technology said. The world’s first and India’s indigenously developed DNA-based vaccine for COVID-19 will be administered in humans including children and adults 12 years and above, the ministry
By Joseph Maliakan The new Bill introduced by the Union government , Viksit Bharat -…
By Joseph Maliakan Betrand Russel, plilosopher and logician was arrested in 1961 at the ripe…
Joseph Maliakan The Supreme Court of India on Thursday 27 November 2025 suggested the Union…
Joseph Maliakan Seven months of January to July 2025 , witnessed an unprecedented 334 incidents…
Muscat : Set to take place in Muscat this October, the 2025 edition of the…
Dubai: ADNOC Gas has entered into a 10-year agreement to supply liquefied natural gas (LNG)…
This website uses cookies.